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periods. Intravenous brinase (100 mg.) increased T cells
from 34% to 85% after ten days, with a fall back to 34%
ten days later. A lymphocyte " wash " on the separator
increased T cells from 34% to 70";, after eight days, but
they were back again at 34% by day 12. There was no
clinical improvement. A fuller report will be published
later.
St Laurence’s Hospital, Dublin;






MECHANISM OF LACTIC ACIDOSIS
SiR,&mdash;I appreciate the comments of Dr Cohen and his
colleagues (Aug. 17, p. 405) concerning the relationship
between lactate utilisation and the pathogenesis of lactic
acidosis. Their suggestion that tissue utilisation of lactate
occurs as the acid rather than the anion is reasonable,
although I am not aware of evidence which supports that
position. Not only may lactate utilisation be associated
with hydrogen-ion consumption, but also the oxidation or
conversion of lactate to glucose by the liver results in
bicarbonate generation; thus, impaired utilisation of
lactate could theoretically cause acidosis by both these
mechanisms.
My letter (June 29, p. 1351) related specifically to the
question of isolated hepatic impairment of lactate utilisa-
tion. I doubt whether selective hepatic inhibition of
lactate utilisation would result in excess hydrogen ions
or a deficit of bicarbonate and systemic lactic acidosis
unless the perfusion and/or utilisation of lactate by all
tissues was concomitantly impaired. While the kidneys
and liver are important in lactate homocostasis the role of
skeletal muscle should not be minimised. Lactate utilisa-
tion by skeletal muscle is a concentration-dependent
process.1,2 ’ When systemic lactate concentrations are
raised net lactate balance across muscle becomes positive.2,:I 3
This suggests that the underutilisation of lactate or over-
production of lactic acid by the liver would not produce
lactic acidosis or hyperlactatxmia due to a concomitant
increase in lactate utilisation by other tissues (skeletal
muscle). The fact that arterial lactate concentrations do
not rise excessively in dogs when hepatic lactate extraction
is inhibited by hypoxxmia and hyperperfusion supports
such a concept. I do not know whether the above concept
would apply in bacteraemic shock, but if perfusion of
skeletal muscle remained intact I see no reason why it
would not. I suspect, however, that the perfusion of all
tissues would be reduced in bacterxmic shock as it is in
other types of low-flow states, thereby impairing the uptake
and/or oxidation of lactate with resulting hydrogen-ion
accumulation and diminished bicarbonate generation.
In patients with clinical lactic acidosis regional measure-
ments indicate that the production of lactic acid is general-
ised.5
Thus, the evidence that Dr Cohen and his colleagues
requested supports the contention that isolated impairment
of lactate utilisation by the liver does not produce lactic
acidosis and that lactic acidosis is predominantly an over-
production acidosis. While underutilisation of lactate may
contribute to lactic acidosis when perfusion of all tissues is
impaired, I am unaware of any clinical or experimental
evidence that supports such a proposal.
Department of Medicine,
University of South Alabama,
Mobile, Alabama 36608, U.S.A. ROBERT A. KREISBERG.
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MINOCYCLINE: POSSIBLE VESTIBULAR
SIDE-EFFECTS
SIR,-In my experience the occurrence of vestibulitis
in association with minocycline (Sept. 28, p. 744) is very
likely. During an epidemic of bronchitis last spring, I
used minocycline almost exclusively, in large numbers of
patients, for I had found other antibiotics virtually in-
effective. Minocycline proved very reliable and effective,
but there were many complaints of giddiness. Only as
recently as this week, I prescribed minocycline for a woman
with severe asthma and bronchitis, and she found that she
could not tolerate it because of weakness and vertigo. It
is a remarkably effective antibiotic, and I would not hesi-
tate to use it again, since the effects are transient and pass
when treatment is stopped. All patients should be cau-
tioned, however, because they may be at risk of falling when
they get out of bed.
The Surgery,
Abbey Street,
Wexford. R. K. DOYLE.
ORIGIN OF MALIGNANT LYMPHOMAS
SIR,-Professor Lennert 1 reported that the initial site
of infiltration of lymph-nodes by lymphoreticular neo-
plasms might indicate whether they are of B or T cell
origin. I wish to present evidence for the early involvement
of the thymus-dependent areas of spleen and lymph-nodes
in a patient with Hodgkin’s disease.
A 71-year-old man had a cceliotomy because of suspected
lymphoma. The spleen, which weighed 215 g., and periaortic
lymph-nodes were removed. Gross examination of the spleen
showed many lymphoid follicles throughout the parenchyma.
Microscopical examination revealed many reactive follicles with
germinal centres in the white pulp and small foci of Hodgkin’s
disease, which were not large enough to be seen grossly. These
foci lay in the area of the perivascular lymphatic sheath (see
accompanying figure), which is a thymus-dependent region.
The lymph-nodes contained similar small foci of Hodgkin’s
disease, mainly in the paracortical or thymus-dependent zone.
Both in the spleen and lymph-nodes the areas of involvement were
characterised by collections of malignant-looking histiocytes
(reticulum cells) including Sternberg-Reed cells, some of which
had the characteristics of " lacunar cells ". In most areas the
1. Lennert, K. Lancet, Sept. 7, 1974, p. 586.
Part of white pulp of spleen containing follicle with germinal
centre and central arteriole.
The lymphoid tissue around the central arteriole (thymus-
dependent area) is partly replaced by a focus of Hodgkm’s
disease. Inset: Sternberg-Reed cell.
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neoplastic cells were accompanied by mixtures of lymphocytes,
eosinophils, and occasional plasma cells. " Focal " involvement
of lymph-nodes by Hodgkin’s disease has been described 2,3;
and Lukes 3 comments on the difficulty of classifying the histo-
logical type of Hodgkin’s disease from such small focal lesions.
The sites of early involvement by lymphomas in lymph-
nodes and spleen are of more than theoretical interest.
They are of practical importance to the pathologist in the
diagnosis of lymphomas, especially in detecting small early
foci in tissue removed at staging coeliotomy.
According to the suggestion of Lennert that the first site
of infiltration in a lymph-node (and, in this instance, also
the first site of infiltration in the spleen) might give an
indication of the origin of the lymphoma, a T-cell origin of
Hodgkin’s disease is favoured.
Department of Pathology,
University of Michigan,
Ann Arbor, Michigan, U.S.A. BERTRAM SCHNITZER.
PHENOLPHTHALEIN IN " ASPIRIN "
SIR,-Not everything in medical textbooks is necessarily
correct. The usual teaching about proprietary preparations
containing more than one drug is that these are undesir-
able. One reason is that flexibility of dose is removed.
In practice, however, some of these mixtures are quite
useful. Many compound mixtures for asthma which
include both ephedrine and theophylline may be singularly
successful: perhaps the drugs potentiate each other and
prevent tachyphylaxis. Also taking one tablet may save
the patient the trouble of coping with two or more pills.
In many cases, compounded mixtures seem to be more
trouble than they are worth. Recently, one of us observed
a new example of this. A 65-year-old man was seen with a
fixed drug eruption. He denied taking any phenolphthalein
laxatives. The only tablet he was taking was " aspirin ".
This, however, was found to be a new preparation which
contained phenolphthalein and codeine in addition to
aspirin. We consider this to be an undesirable mixture of
drugs to be taken over long periods. The continued use of
irritant purgatives is hazardous and the increasing aware-
ness of this has greatly diminished their use in clinical
practice.
The incorporation of phenolphthalein into an analgesic
preparation which could be taken over prolonged periods
appears to be a retrograde step.





SIR,-Your review (Aug. 10, p. 323) states baldly
about Russian methods " that a system of nurse training
which... leaves nursing administration and supervision
in medical hands " is not preferable to our own system.
This would be understandable if our own system were not
inefficient with an inherently high wastage. Our system
produces some good and some very good nurses, but there
are far too many nurses who, during their training or as
soon as they qualify, drop out of nursing. The major reason
is the hieratic authoritarian system they have met during
their training. Most of the nurses on the Salmon Committee
were nurses who had foregone the care of patients and
seemed at times to believe that the pursuit of administra-
tive efficiency rather than good patient care was the
s/lmmum bonum of the nursing service. To end the review
with the suggestion that our own rigidities have been less
inhibiting than those of the U.S.S.R. is to neglect to
2. Strum, S. B , Rappaport, H. Cancer, 1970, 25, 1314.
3. Lukes, R. J. Cancer Res. 1971, 31, 1755.
consider the sad inadequacies of the present system of
nurse training in our country.
35 Bloomfield Terrace,
London SW1. R. C. MAC KEITH.
CLASSIFICATION OF NON-HODGKIN’S
LYMPHOMAS
SiR;&mdash;My colleagues and I derived great amusement from
Dr Kay’s letter (Sept. 7, p. 586). By all means, let us retain
our sense of humour about the current controversy over
the classification of non-Hodgkin’s lymphomas. I find
this rather difficult, however, in the face of the implications
of the opening sentence in the letter by Dr Bennett and his
colleagues (Aug. 17, p. 405). I clearly acknowledged their
classification in my statement: " In order to reach a com-
promise between the concepts of Rappaport ... those
recently propounded by Lukes and those of Farrer-Brown,
Bennett, and Henry in England ..." Furthermore, it is
ironical that, as far as I am aware, the only previously
published report and discussion of their classification
appears in a paper by Berard and me and it is my under-
standing that a preprint of this paper was reviewed by
Bennett and his associates. It is, nevertheless, some con-
solation to me that I have stimulated Bennett et al. to put
pen to paper.
In the interest of amicable transatlantic relations, I
sincerely hope that we can reach a compromise since there
is no doubt about the similarity of the proposed classifica-
tions. It is equally evident, however, that there are differ-
ences of opinion which need clarification. I indicated in my
previous letter that there are many who criticise the
concept of 
" differentiation " of lymphocytes and I have
thus eliminated this term from my classification. I also
feel it is essential to include Burkitt’s lymphoma as a
distinct entity, despite accumulating evidence supporting
its origin from lymphocytes bearing both B 2 and T 3 cell
markers. The clinicopathological manifestations of
Burkitt’s lymphoma  and its response to therapy are so
distinctive that its elimination from any histopathological
classification would meet with the strong disapproval of
oncologists, haematologists, immunologists, and many other
individuals involved in the investigation of this type of
lymphoma. I certainly concur with the observation that
plasmacytoid differentiation may be seen in association with
both small and large lymphoid lymphomas and I am thus
quite happy to accept this modification. It is, however,
questionable whether extramedullary plasmacytoma should
be included in a classification of non-Hodgkin’s lymphoma,
merely on the basis of origin from B lymphocytes. Multiple
myeloma is more akin to the leukxmias, and several of
the leukxmias are presumed to be derived from lympho-
cytes of either B or T cell type. From a practical standpoint
the management of myeloma and of extramedullary
plasmacytoma is so different from that of the non-Hodg-
kin’s lymphomas that these are best eliminated from this
classification. I see no reason, however, to omit mycosis
fungoides. Evidence is accumulating to support the con-
cept that this disease is a distinct pathological entity and
that the predominant cell is an atypical lymphocyte ’* most
probably of T-cell type. This applies equally to Sezary’s
syndrome.’’
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